Speaker 1: Bloomberg Audio Studios, podcasts, radio news, The.
Speaker 2: Stock Movers Report, your roundup of companies making moves in
Speaker 2: the stock market, harnessing the power of Bloomberg Data.
Speaker 1: We have Avlon Parnell here with us to talk us
Speaker 1: through some of the big movers. She sees, Alan, what
Speaker 1: do you have for us? Yeah, we can go, and
Speaker 1: to start off with probably the biggest one of today. Intel,
Speaker 1: that's ticker i NTC jumping now about twenty four percent
Speaker 1: for it is to hit a record high. Actually that's
Speaker 1: after Intel reported a really big beat last night and
Speaker 1: also a stronger than expected second quarter forecast. Ever, of course,
Speaker 1: actually writing that the company's new CEO really seems to
Speaker 1: be executing on a strategy that seems to be making
Speaker 1: Intel back onto the competitive track, and also worth mentioning
Speaker 1: that this is all basically based on AI.
Speaker 3: So yeah, it's not a bit of an amazing, amazing
Speaker 3: move here. How about a cable and broadband company, Charter Communications.
Speaker 3: We had good numbers out of coompcast yesterday. That stock
Speaker 3: was up much for Charter today.
Speaker 1: Exactly, Charter that's ticker cht R struggling today to say
Speaker 1: the least, down a roety about twenty three percent for
Speaker 1: its biggest inter day drop on record. That's after the
Speaker 1: cable company, as you mentioned behind Spectrum, reported weaker than
Speaker 1: expected first quarter results. City writing that Charter's results were
Speaker 1: mixed as strategic volumes and also that broadband revenue underwhelmed,
Speaker 1: and also thought it was really interesting because, as you said,
Speaker 1: Comcast was a basically completely different story.
Speaker 3: Yep, yep, And so that's sort of expectations. I think.
Speaker 1: Yeah, let's take a look at big pharma. Yes, Eli,
Speaker 1: Lilly that's ticker ll Y also sliding about four point
Speaker 1: two percent today to hit its lowest inter day level
Speaker 1: since March, and that's after early prescription scripts data for
Speaker 1: its long awaited weight loss pill very much disappointed Wall Street.
Speaker 1: Lily's fat loss pill FOUNDEO generated just under four thousand
Speaker 1: prescriptions and it's second week since launching. By comparison, Novo's
Speaker 1: wig Govi pill got more than eighteen thousand prescriptions. So
Speaker 1: while it's still way too early to say this is
Speaker 1: a good or bad situation, RBC is actually writing that
Speaker 1: while the comparisons this early into a launch are very
Speaker 1: much immateial Vondeo's uptake this week is likely to be
Speaker 1: received very negatively by investors, and we're already seeing that
Speaker 1: in the stock move.
Speaker 2: The stock Moover's report from Bloomberg Radio. Check back with
Speaker 2: us throughout the day for the latest roundup of companies
Speaker 2: making news on Wall Street and for the latest market
Speaker 2: moving headlines. Listen to Bloomberg Radio Live, catch us on YouTube,
Speaker 2: Bloomberg dot com, and on Applecarplay and Android Auto with
Speaker 2: the Bloomberg Business app.